Canada Life’s Epizyme, Inc EPZM Stock Holding History

Canada Life’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,799	Closed	-$7K	–	2485
2022 Q1	$7K	Buy	5,799 +682	+13%	+$1.11K	﹤0.01%	2458
2021 Q4	$13K	Buy	5,117 +612	+14%	+$2.4K	﹤0.01%	2431
2021 Q3	$23K	Hold	4,505	–	–	﹤0.01%	2407
2021 Q2	$37K	Hold	4,505	–	–	﹤0.01%	2355
2021 Q1	$39K	Hold	4,505	–	–	﹤0.01%	2371
2020 Q4	$49K	Hold	4,505	–	–	﹤0.01%	2286
2020 Q3	$54K	Hold	4,505	–	–	﹤0.01%	2163
2020 Q2	$72K	Hold	4,505	–	–	﹤0.01%	2133
2020 Q1	$70K	Hold	4,505	–	–	﹤0.01%	2054
2019 Q4	$110K	Buy	+4,505	New	+$66.9K	﹤0.01%	2056
2019 Q3	–	Sell	-11,099	Closed	-$139K	–	2515
2019 Q2	$139K	Buy	11,099 +6,299	+131%	+$81K	﹤0.01%	2122
2019 Q1	$59K	Hold	4,800	–	–	﹤0.01%	2222
2018 Q4	$28K	Hold	4,800	–	–	﹤0.01%	2502
2018 Q3	$51K	Hold	4,800	–	–	﹤0.01%	2393
2018 Q2	$65K	Hold	4,800	–	–	﹤0.01%	2339
2018 Q1	$85K	Hold	4,800	–	–	﹤0.01%	2215
2017 Q4	$60K	Hold	4,800	–	–	﹤0.01%	2315
2017 Q3	$87K	Hold	4,800	–	–	﹤0.01%	2190
2017 Q2	$72K	Hold	4,800	–	–	﹤0.01%	2210
2017 Q1	$82K	Hold	4,800	–	–	﹤0.01%	2172
2016 Q4	$58K	Hold	4,800	–	–	﹤0.01%	2283
2016 Q3	$47K	Hold	4,800	–	–	﹤0.01%	2348
2016 Q2	$49K	Hold	4,800	–	–	﹤0.01%	2319
2016 Q1	$58K	Hold	4,800	–	–	﹤0.01%	2067
2015 Q4	$77K	Hold	4,800	–	–	﹤0.01%	1936
2015 Q3	$62K	Buy	+4,800	New	+$96.9K	﹤0.01%	1993

Other funds holding EPZM

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Life's EPZM Position: Q2 2022 in Review

Canada Life sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 5,799 shares — an estimated $7K sold.

Canada Life first reported a position in EPZM in Q3 2015 and held it in 26 quarters. The position peaked at $139K in Q2 2019. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

Canada Life reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
Canada Life sold 5,799 Epizyme, Inc shares in Q2 2022, an estimated $7K.
Canada Life first reported a position in Epizyme, Inc in Q3 2015 and held it in 26 quarters.
Canada Life's Epizyme, Inc position peaked at $139K in Q2 2019.
93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.